Literature DB >> 11490207

Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract.

F Koga1, H Nagamatsu, H Ishimaru, T Mizuo, K Yoshida.   

Abstract

To determine the risk factors for development of transitional cell carcinoma (TCC) of the bladder (BTCC) following surgery for TCC of the upper urinary tract (UUT-TCC) in patients without history of BTCC, 85 patients surgically treated for UUT-TCC (34 female, 51 male; median age 66, range 42-85 years) were reviewed retrospectively. The Cox proportional hazards model was used to assess the association of relevant clinicopathologic factors with BTCC-free survival in patients without a history of BTCC and TCC-specific survival in all. Median follow-up duration was 35 (range 1-193) months. Six patients (7%) had previous histories of BTCC, and 6 others (7%) had concurrent BTCC at the time of surgery for UUT-TCC. Of 70 patients who had no history of BTCC and underwent follow-up cystoscopy, 24 (34%) developed BTCC during follow-up after surgery. Univariate analysis identified female sex, postoperative systemic chemotherapy, and incomplete distal ureterectomy as significant risk factors for new development of BTCC. After multivariate analysis adjusted for age and pathological (p) T stage in the TNM classification, all three factors remained significant, with respective hazard ratios of 5.56 (95% confidence interval (CI), 1.99-15.6; p = 0.001), 3.19 (95% CI, 1.34-7.62; p = 0.009) and 2.99 (95% CI, 1.08-8.26; p = 0.03). Only pT stage was a significant independent risk factor for TCC-specific death. Female sex and postoperative systemic chemotherapy, as well as incomplete distal ureterectomy, are possible riks factors for development of BTCC following surgery for UUT-TCC. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11490207     DOI: 10.1159/000050969

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Samer El-Halwagy
Journal:  Turk J Urol       Date:  2018-03-06

2.  Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival.

Authors:  Bogomir Milojevic; Milan Djokic; Sandra Sipetic-Grujicic; Dragica Milenkovic-Petronic; Aleksandar Vuksanovic; Dejan Dragicevic; Uros Bumbasirevic; Cane Tulic
Journal:  Int Urol Nephrol       Date:  2011-02-26       Impact factor: 2.370

3.  Prognostic factors for upper urinary tract urothelial carcinomas: stage, grade, and smoking status.

Authors:  Adnan Simsir; Banu Sarsik; Ibrahim Cureklibatir; Sait Sen; Gurhan Gunaydin; Cag Cal
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

4.  Pure laparoscopic complete excision of distal ureter with a bladder cuff for upper tract urothelial carcinoma.

Authors:  Ryohei Hattori; Yasushi Yoshino; Tomonori Komatsu; Yoshihisa Matsukawa; Yoshinari Ono; Momokazu Gotoh
Journal:  World J Urol       Date:  2008-10-10       Impact factor: 4.226

5.  P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.

Authors:  Banu Sarsik; Basak Doganavsargil; Adnan Simsir; Ayse Yazici; Burcin Pehlivanoglu; Cag Cal; Sait Sen
Journal:  Pathol Oncol Res       Date:  2016-05-24       Impact factor: 3.201

6.  Age-specific effect of gender on upper tract urothelial carcinoma outcomes.

Authors:  Jian-Ye Liu; Yong-Hong Li; Zhi-Ling Zhang; Yun-Lin Ye; Zhou-Wei Liu; Kai Yao; Pei Dong; Sheng-Jie Guo; Li-Juan Jiang; Ming-Zhu Zhong; Wei Chen; Hui Han; Zi-Ke Qin; Fang-Jian Zhou
Journal:  Med Oncol       Date:  2013-06-19       Impact factor: 3.064

7.  Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Mohamed H Zahran; Samer El-Halwagy; Muftah El Garba; Ahmed M Harraz
Journal:  Arab J Urol       Date:  2017-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.